Dataset from A Phase 1/1b, Open-label Study of Pevonedistat (MLN4924, TAK-924) as Single Agent and in Combination With Azacitidine in Adult East Asian Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/PR00008402
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the safety and tolerability of pevonedistat
administered as a single agent and in combination with azacitidine in adult east Asian
participants with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS).
创建时间：
2025-10-01
